Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the ...

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its ...

A new survey from Dexcom suggests that living with Type 2 diabetes can have significant impacts not only on physical health ...

A decade ago, with AstraZeneca in decline and some investors urging the drugmaker to sell out to Pfizer, new CEO Pascal ...

The biologics market for inflammatory bowel disease is continually getting more competitive, and now Johnson & Johnson’s ...

Even as GSK defends itself against thousands of personal injury lawsuits relating to its sale of heartburn pill Zantac, a ...

Japan’s Astellas Pharma and Yaskawa Electric Corporation inked an agreement to explore the development of an automated cell ...

Havas is rebranding its health network, launching new global agencies as part of a reshuffle that will put most of its groups ...

At the American Thoracic Society (ATS) international conference in San Diego, one of the major themes is the advance of new ...

As some industry efforts to deliver vaccines to Africa have fallen by the wayside, Serum Institute of India (SII), together ...

Four months after Europe's drug reviewers doubled down and recommended the withdrawal of PTC Therapeutics' Translarna for ...

Sanofi and Regeneron’s Dupixent appears set up for a key FDA approval this summer for chronic obstructive pulmonary disorder ...